Pharmasset Inc. (VRUS) Key Ratios

Profile for Pharmasset Inc.  (VRUS) 
$ N/A N/A (N/A) Volume: N/A
Income Statements
Revenue (LTM) ($): 897 k
Revenue per Share (LTM) ($): 0.01
Revenue per Employee (LTM) ($): 10,939.02
Revenue Growth 3 Yr: -37.82%
Revenue Growth 5 Yr: -37.13%
 
Dividends & Splits
Annual Dividend Rate ($): N/A
Annual Dividend Yield: N/A
Dividend Growth 3 Yr: N/A
Dividend Growth 5 Yr: N/A
Ex-Dividend Date: N/A
Payment Type: N/A
Financial Strength (LTM)
Quick Ratio: 10.20
Current Ratio: 10.40
Long Term Debt to Total Capital: N/A
Total Debt to Equity: 0.02
Interest Coverage: N/A
Leverage Ratio: 1.10
 
Profitability (LTM)
Gross Margin: N/A
EBIT Margin: N/A
EBITDA Margin: N/A
Pre-Tax Profit Margin: N/A
Profit Margin (Cont. Op): N/A
Profit Margin (Total Op): N/A
Management Effectiveness LTM 5 Yr Avg
Return on Equity N/A N/A
Return on Capital -66.00% -66.00%
Return on Assets -53.50% -53.50%
 
Assets
Asset Turnover: N/A
Inventory Turnover: N/A
Receivable Turnover: 299.00
Valuation Measures
P/E Ratio: N/A
P/E High - Last 5 Years: N/A
P/E Avg. High - Last 5 Years: N/A
P/E Low - Last 5 Years: N/A
P/E Avg. Low - Last 5 Years: N/A
 
Price to Sales: 0.00
Price to Book: 67.16
Price to Tangible Book: 67.16
Price to Cash Flow: -114.40
Price to Free Cash: -122.00